Blue Water Life Science Advisors, LP Guardant Health, Inc. Transaction History
Blue Water Life Science Advisors, LP
- $114 Million
- Q3 2024
A detailed history of Blue Water Life Science Advisors, LP transactions in Guardant Health, Inc. stock. As of the latest transaction made, Blue Water Life Science Advisors, LP holds 451,047 shares of GH stock, worth $14.7 Million. This represents 9.09% of its overall portfolio holdings.
Number of Shares
451,047
Previous 571,047
21.01%
Holding current value
$14.7 Million
Previous $16.5 Million
37.29%
% of portfolio
9.09%
Previous 16.04%
Shares
13 transactions
Others Institutions Holding GH
# of Institutions
323Shares Held
127MCall Options Held
844KPut Options Held
2.38M-
Vanguard Group Inc Valley Forge, PA11.7MShares$382 Million0.0% of portfolio
-
Black Rock Inc. New York, NY11.2MShares$367 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA10.1MShares$331 Million0.04% of portfolio
-
Cadian Capital Management, LP New York, NY6.93MShares$226 Million8.13% of portfolio
-
Deep Track Capital, LP Greenwich, CT6MShares$196 Million5.07% of portfolio
About Guardant Health, Inc.
- Ticker GH
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 102,220,000
- Market Cap $3.34B
- Description
- Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...